TNFRSF1A and Hepatic fibrosis: Taken together, these studies emphasize the profibrotic role of TNFR1 in the liver, regardless of the model, and indicate that selective TNFR1 inhibition could be a promising therapeutic approach for treatment of liver fibrosis.